Drug interactions
Palbociclib + Palifermin
Severity: Minor
Palbociclib and Palifermin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Palifermin given close to cytotoxic chemotherapy has been associated with more severe and longer oral mucositis. Palbociclib is an oral CDK4/6 inhibitor given continuously, and the relevance of this timing restriction is uncertain.
What this interaction means in plain words
Palbociclib and Palifermin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Palbociclib belongs to Oncology; Palifermin belongs to Miscellaneous.
Why it happens
Palifermin stimulates epithelial cell proliferation, which may increase sensitivity of rapidly dividing cells to antiproliferative drugs; the effect with palbociclib is not established.
What to do
Palifermin is intended for hematologic malignancy conditioning regimens, so coadministration is uncommon. If both are used, monitor for oral mucositis.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Palbociclib and Palifermin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Palbociclib
Other interactions of Palifermin
Frequently asked questions
Can I take Palbociclib with Palifermin?
MediHelp rates the interaction as minor. Palbociclib and Palifermin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Palifermin given close to cytotoxic chemotherapy has been associated with more severe and longer oral mucositis. Palbociclib is an oral CDK4/6 inhibitor given continuously, and the relevance of this timing restriction is uncertain.
How serious is the interaction between Palbociclib and Palifermin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Palifermin is intended for hematologic malignancy conditioning regimens, so coadministration is uncommon. If both are used, monitor for oral mucositis.
What other medicines interact with Palbociclib?
MediHelp also lists interactions of Palbociclib with, for example, Apalutamide, Atazanavir, Carbamazepine. The full list is on the Palbociclib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.